Apotheek Vanhoutte Lore: what changed
What changed
Apotheek Vanhoutte Lore
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Net result for the year
€212,113
2024 · €185,110+€27,003
Equity
€183,256
2024 · €181,143+€2,113
Cash
€166,459
2024 · €90,731+€75,728
Balance sheet total
€480,355
2024 · €448,552+€31,803
Largest movements
Assets
- Cash +€75,728
up €75,728 (+83.5%), from €90,731 to €166,459
mainly Net result for the year (+€212,113) and Receivables within one year (+€66,439)
- Receivables within one year -€66,439
down €66,439 (-38.5%), from €172,745 to €106,305
of which Other amounts receivable: -€47,788
- Stocks and contracts +€27,720
up €27,720 (+19.4%), from €142,890 to €170,609
- Tangible fixed assets -€4,951
down €4,951 (-22.4%), from €22,093 to €17,142
Equity and liabilities
- Other debts +€20,008
up €20,008 (+10.0%), from €200,113 to €220,121
- Trade debts +€9,329
up €9,329 (+13.9%), from €67,094 to €76,422
Income statement
- Gross operating margin +€34,145
up €34,145 (+18.1%), from €188,707 to €222,852
- Staff costs +€5,670
up €5,670 (+1,268%), from €447 to €6,118
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€185,110
Gross operating margin
+€34,145
Staff costs
-€5,670
Depreciation
-€481
Other operating charges
+€125
Financial income
-€239
Financial charges
-€303
Taxes
-€574
Result 2025
€212,113
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€285,728
Investment
€0
Financing
-€210,000
Cash 2024
€90,731
From operations (derived)
+€285,728
Net result for the year
+€212,113
Depreciation
+€4,951
Stocks and contracts
-€27,720
Receivables within one year
+€66,439
Smaller working-capital items
+€609
Trade debts
+€9,329
Other debts
+€20,008
Financing
-€210,000
Contributions, distributions and other
-€210,000
Cash 2025
€166,459
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €448,552 | €480,355 | +€31,803 | +7.1% |
| Fixed assets | 21/28 | €32,342 | €27,391 | -€4,951 | -15.3% |
| Tangible fixed assets | 22/27 | €22,093 | €17,142 | -€4,951 | -22.4% |
| Plant, machinery and equipment | 23 | €7,322 | €5,067 | -€2,255 | -30.8% |
| Furniture and vehicles | 24 | €2,402 | €1,503 | -€899 | -37.4% |
| Other tangible fixed assets | 26 | €12,370 | €10,573 | -€1,797 | -14.5% |
| Financial fixed assets | 28 | €10,249 | €10,249 | = | 0.0% |
| Current assets | 29/58 | €416,209 | €452,963 | +€36,754 | +8.8% |
| Stocks and contracts in progress | 3 | €142,890 | €170,609 | +€27,720 | +19.4% |
| Stocks | 30/36 | €142,890 | €170,609 | +€27,720 | +19.4% |
| Amounts receivable within one year | 40/41 | €172,745 | €106,305 | -€66,439 | -38.5% |
| Trade receivables | 40 | €87,202 | €68,551 | -€18,652 | -21.4% |
| Other amounts receivable | 41 | €85,542 | €37,755 | -€47,788 | -55.9% |
| Cash at bank and in hand | 54/58 | €90,731 | €166,459 | +€75,728 | +83.5% |
| Deferred charges and accrued income | 490/1 | €9,844 | €9,589 | -€255 | -2.6% |
| Total equity and liabilities | 10/49 | €448,552 | €480,355 | +€31,803 | +7.1% |
| Equity | 10/15 | €181,143 | €183,256 | +€2,113 | +1.2% |
| Contributions | 10/11 | €18,592 | €18,592 | = | 0.0% |
| Reserves | 13 | €162,551 | €164,664 | +€2,113 | +1.3% |
| Non-distributable reserves | 130/1 | €0 | - | = | |
| Reserves not available under the articles | 1311 | €0 | - | = | |
| Tax-exempt reserves | 132 | €37,500 | €37,500 | = | 0.0% |
| Distributable reserves | 133 | €125,051 | €127,164 | +€2,113 | +1.7% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €267,409 | €297,099 | +€29,690 | +11.1% |
| Amounts payable within one year | 42/48 | €267,218 | €296,907 | +€29,689 | +11.1% |
| Trade debts | 44 | €67,094 | €76,422 | +€9,329 | +13.9% |
| Suppliers | 440/4 | €67,094 | €76,422 | +€9,329 | +13.9% |
| Taxes, remuneration and social security | 45 | €11 | €364 | +€353 | +3,280% |
| Taxes | 450/3 | €11 | €364 | +€353 | +3,280% |
| Remuneration and social security | 454/9 | €0 | - | = | |
| Other amounts payable | 47/48 | €200,113 | €220,121 | +€20,008 | +10.0% |
| Accrued charges and deferred income | 492/3 | €191 | €192 | +€1 | +0.5% |
| Remuneration, social security and pensions | 62 | €447 | €6,118 | +€5,670 | +1,268% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €4,470 | €4,951 | +€481 | +10.8% |
| Other operating charges | 640/8 | €633 | €509 | -€125 | -19.7% |
| Gross operating margin | 9900 | €188,707 | €222,852 | +€34,145 | +18.1% |
| Operating profit (loss) | 9901 | €183,157 | €211,275 | +€28,118 | +15.4% |
| Financial income | 75/76B | €3,003 | €2,764 | -€239 | -8.0% |
| Recurring financial income | 75 | €3,003 | €2,764 | -€239 | -8.0% |
| Financial charges | 65/66B | €373 | €676 | +€303 | +81.1% |
| Recurring financial charges | 65 | €373 | €676 | +€303 | +81.1% |
| Profit (loss) for the period before taxes | 9903 | €185,787 | €213,363 | +€27,576 | +14.8% |
| Income taxes | 67/77 | €676 | €1,250 | +€574 | +84.8% |
| Profit (loss) for the period | 9904 | €185,110 | €212,113 | +€27,003 | +14.6% |
| Profit (loss) for the period to be appropriated | 9905 | €185,110 | €212,113 | +€27,003 | +14.6% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 4 November 2026 via checked.be.